# Tvardi Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Apr 16, 2025

- Company: [Tvardi Therapeutics, Inc.](/companies/tvrd.md) (CIK 1346830)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-16
- Accepted by EDGAR: Apr 16, 2025, 16:15 ET
- Period: not reported
- Accession: 0000950170-25-054743
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1346830/000095017025054743/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1346830/000095017025054743/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1346830/000095017025054743/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 16, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-054743. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.